Literature DB >> 29199134

The importance of fungal pathogens and antifungal coatings in medical device infections.

Carla Giles1, Stephanie J Lamont-Friedrich1, Thomas D Michl1, Hans J Griesser1, Bryan R Coad2.   

Abstract

In recent years, increasing evidence has been collated on the contributions of fungal species, particularly Candida, to medical device infections. Fungal species can form biofilms by themselves or by participating in polymicrobial biofilms with bacteria. Thus, there is a clear need for effective preventative measures, such as thin coatings that can be applied onto medical devices to stop the attachment, proliferation, and formation of device-associated biofilms. However, fungi being eukaryotes, the challenge is greater than for bacterial infections because antifungal agents are often toxic towards eukaryotic host cells. Whilst there is extensive literature on antibacterial coatings, a far lesser body of literature exists on surfaces or coatings that prevent attachment and biofilm formation on medical devices by fungal pathogens. Here we review strategies for the design and fabrication of medical devices with antifungal surfaces. We also survey the microbiology literature on fundamental mechanisms by which fungi attach and spread on natural and synthetic surfaces. Research in this field requires close collaboration between biomaterials scientists, microbiologists and clinicians; we consider progress in the molecular understanding of fungal recognition of, and attachment to, suitable surfaces, and of ensuing metabolic changes, to be essential for designing rational approaches towards effective antifungal coatings, rather than empirical trial of coatings.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antimicrobial surface; Candida; Fungal disease; Medical devices; Mold; Mycoses; Surface modification; Yeast

Mesh:

Substances:

Year:  2017        PMID: 29199134     DOI: 10.1016/j.biotechadv.2017.11.010

Source DB:  PubMed          Journal:  Biotechnol Adv        ISSN: 0734-9750            Impact factor:   14.227


  6 in total

1.  Rational selection of antifungal drugs to propose a new formulation strategy to control Candida biofilm formation on venous catheters.

Authors:  Paula Reginatto; Vanessa Zafanelli Bergamo; Simone Jacobus Berlitz; Irene Clemes Kulkamp Guerreiro; Saulo Fernandes de Andrade; Alexandre Meneghello Fuentefria
Journal:  Braz J Microbiol       Date:  2020-02-19       Impact factor: 2.476

Review 2.  The International Penile Prosthesis Implant Consensus Forum: clinical recommendations and surgical principles on the inflatable 3-piece penile prosthesis implant.

Authors:  Eric Chung; Carlo Bettocchi; Paulo Egydio; Chris Love; Daniar Osmonov; Sean Park; David Ralph; Zhong Cheng Xin; Gerald Brock
Journal:  Nat Rev Urol       Date:  2022-06-16       Impact factor: 16.430

Review 3.  Surface treatment strategies to combat implant-related infection from the beginning.

Authors:  Minqi Wang; Tingting Tang
Journal:  J Orthop Translat       Date:  2018-09-28       Impact factor: 5.191

Review 4.  Bioactive Peptides Against Fungal Biofilms.

Authors:  Karen G N Oshiro; Gisele Rodrigues; Bruna Estéfani D Monges; Marlon Henrique Cardoso; Octávio Luiz Franco
Journal:  Front Microbiol       Date:  2019-10-04       Impact factor: 5.640

5.  The Evolutionary Conserved γ-Core Motif Influences the Anti-Candida Activity of the Penicillium chrysogenum Antifungal Protein PAF.

Authors:  Christoph Sonderegger; Györgyi Váradi; László Galgóczy; Sándor Kocsubé; Wilfried Posch; Attila Borics; Sandrine Dubrac; Gábor K Tóth; Doris Wilflingseder; Florentine Marx
Journal:  Front Microbiol       Date:  2018-07-20       Impact factor: 5.640

Review 6.  Trends in Managing Cardiac and Orthopaedic Device-Associated Infections by Using Therapeutic Biomaterials.

Authors:  Stefania Scialla; Giorgia Martuscelli; Francesco Nappi; Sanjeet Singh Avtaar Singh; Adelaide Iervolino; Domenico Larobina; Luigi Ambrosio; Maria Grazia Raucci
Journal:  Polymers (Basel)       Date:  2021-05-12       Impact factor: 4.329

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.